Home       Privacy       Archive       Realtime Report



Stock Trading History of Hudak James B

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Hudak James B since year 2005. The trader's CIK number is 1381321. At the time of this reporting, Hudak James B is the Director of Proxymed Inc /ft Lauderdale/ (stock ticker symbol PILL).

Stock purchases, sales, and option exercises reported by Hudak James B since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2007-03-19 PILL Proxymed Inc /ft Lauderdale/ Purchase 24,200 2.94 71,269
2006-12-20 PILL Proxymed Inc /ft Lauderdale/ Purchase 5,000 4.50 22,500
2006-12-21 PILL Proxymed Inc /ft Lauderdale/ Purchase 4,396 4.48 19,673
2006-12-15 PILL Proxymed Inc /ft Lauderdale/ Purchase 4,000 4.50 18,000
2006-12-06 PILL Proxymed Inc /ft Lauderdale/ Purchase 6,604 4.50 29,718

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hudak James B (Director of Proxymed Inc /ft Lauderdale/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.